Comments
Loading...
CVS Health Insider Trading Activity | NYSE:CVS | Benzinga
Track the latest CVS Health insider trading activity. Stay informed on recent buys, sells, and market impact for CVS Health stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are CVS Health Corp Insiders Doing?
At CVS Health Corp, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 19, 2025, Michael F Mahoney, the company's DIRECTOR purchased 30K shares for $66.7 each.
Ownership Statistics for CVS Health Corp
Shares Outstanding
1.261B
Insider Shares Owned
5.522M
Insider Percentage Owned
0.44%
Institutional Shares Held
767.525M
Institutional Percentage Held
60.9%
| Mar 07, 2025 | James D. Clark | SVP, CONT & CHIEF ACCT OFFICER | 0.00 | $64.28 | -$31.10K | SELL-OPTIONS | 0.00% | 8.39K | Mar 05 | View |
| Feb 19, 2025 | Michael F Mahoney | DIRECTOR | 30.00K | $66.70 | $2.00M | BUY | 192.84% | 45.56K | Feb 18 | View |
| May 02, 2024 | Edward J Ludwig | DIRECTOR | 1.00K | $53.88 | $53.88K | BUY | 3.15% | 32.71K | May 02 | View |
| May 02, 2024 | Michael F Mahoney | DIRECTOR | 9.18K | $54.49 | $500.29K | BUY | 460.89% | 11.17K | May 02 | View |
| Feb 16, 2024 | Prem S Shah | EVP AND PRES-PHARM, CONSUMER W | -29.47K | $76.95 | -$2.27M | SELL | -40.60% | 43.12K | Feb 16 | View |
| Nov 06, 2023 | Edward J Ludwig | DIRECTOR | 2.00K | $70.47 | $140.93K | BUY | 6.73% | 31.71K | Nov 03 | View |
| Aug 04, 2023 | James D. Clark | SVP, CONT & CHIEF ACCT OFFICER | -25.76K | $74.92 | -$1.93M | SELL | -65.48% | 13.58K | Aug 03 | View |
| May 05, 2023 | Karen S Lynch | PRESIDENT AND CEO | 14.00K | $69.75 | $976.57K | BUY | 3.35% | 431.39K | May 03 | View |
| Dec 16, 2022 | Thomas M Moriarty | EVP & GENERAL COUNSEL | 0.00 | $86.10 | -$3.37M | SELL-OPTIONS | 0.00% | 655.45K | Dec 15 | View |
| Aug 05, 2022 | Alan Lotvin | EVP&PRESIDENT-PHARMACYSERVICES | 0.00 | $78.21 | -$5.95M | SELL-OPTIONS | 0.00% | 139.36K | Aug 03 - Aug 04 | View |
| Aug 05, 2022 | Daniel P Finke | EVP/PRES, HEALTH CARE BENEFITS | 0.00 | $76.19 | -$454.68K | SELL-OPTIONS | 0.00% | 35.27K | Aug 03 | View |
| Jun 30, 2022 | Thomas M Moriarty | EVP & GENERAL COUNSEL | 0.00 | $78.15 | -$4.67M | SELL-OPTIONS | 0.00% | 626.27K | Jun 28 | View |
| Apr 12, 2022 | Prem S Shah | EVP AND CO-PRESIDENT RETAIL | -3.13K | $83.68 | -$918.03K | SELL | -5.88% | 50.09K | Apr 08 | View |
| Apr 06, 2022 | Daniel P Finke | EVP/PRES, HEALTH CARE BENEFITS | -17.97K | $78.45 | -$3.68M | SELL | -33.77% | 35.25K | Apr 04 - Apr 05 | View |
| Mar 31, 2022 | Prem S Shah | EVP AND CO-PRESIDENT RETAIL | 0.00 | $103.48 | -$13.04K | SELL-OPTIONS | 0.00% | 64.74K | Mar 30 | View |
| Mar 18, 2022 | Prem S Shah | EVP AND CO-PRESIDENT RETAIL | -1.69K | $105.73 | -$185.50K | SELL | -2.54% | 64.74K | Mar 17 | View |
| Mar 17, 2022 | Thomas M Moriarty | EVP & GENERAL COUNSEL | 0.00 | $103.63 | -$140.73K | SELL-OPTIONS | 0.00% | 934.63K | Mar 15 | View |
| Feb 11, 2022 | Edward J Ludwig | DIRECTOR | 1.00K | $105.90 | $105.90K | BUY | 3.52% | 29.41K | Feb 10 | View |
| Feb 04, 2022 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $106.13 | -$371.03K | SELL-OPTIONS | 0.00% | 143.05K | Feb 03 | View |
| Feb 02, 2022 | Alan Lotvin | EVP&PRESIDENT-PHARMACYSERVICES | 0.00 | $104.38 | -$90.63K | SELL-OPTIONS | 0.00% | 91.19K | Feb 01 | View |
| Feb 01, 2022 | James D. Clark | SVP, CONT & CHIEF ACCT OFFICER | 0.00 | $105.63 | -$40.84K | SELL-OPTIONS | 0.00% | 34.42K | Jan 28 | View |
| Jan 28, 2022 | Jonathan C Roberts | EVP & CHIEF OPERATING OFFICER | 0.00 | $104.88 | -$358.85K | SELL-OPTIONS | 0.00% | 113.16K | Jan 27 | View |
| Nov 05, 2021 | Jonathan C Roberts | EVP & CHIEF OPERATING OFFICER | 0.00 | $70.47 | -$5.34M | SELL-OPTIONS | 0.00% | 444.95K | Nov 03 | View |
| Nov 03, 2021 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $74.17 | -$891.51K | SELL-OPTIONS | 0.00% | 143.05K | Nov 01 | View |
| Oct 28, 2021 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | -1.96K | $71.09 | -$2.90M | SELL | -1.35% | 143.05K | Oct 26 | View |
| Sep 07, 2021 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | -2.63K | $87.00 | -$228.38K | SELL | -1.78% | 145.01K | Sep 02 | View |
| Aug 05, 2021 | Edward J Ludwig | DIRECTOR | 3.00K | $79.55 | $238.63K | BUY | 11.80% | 28.41K | Aug 05 | View |
| Jun 29, 2021 | Alan Lotvin | EVP&PRESIDENT-PHARMACYSERVICES | -2.78K | $83.67 | -$232.69K | SELL | -2.98% | 90.55K | Jun 28 | View |
| Jun 17, 2021 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | -1.87K | $74.11 | -$1.72M | SELL | -1.25% | 147.63K | Jun 15 | View |
| Jun 08, 2021 | Daniel P Finke | EVP/PRES, HEALTH CARE BENEFITS | -5.27K | $70.39 | -$1.50M | SELL | -9.72% | 49.01K | Jun 07 | View |
| May 12, 2021 | Thomas M Moriarty | EVP & GENERAL COUNSEL | 0.00 | $74.11 | -$2.60M | SELL-OPTIONS | 0.00% | 45.75K | May 10 | View |
| May 10, 2021 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | -9.48K | $84.00 | -$796.07K | SELL | -5.96% | 149.50K | May 07 | View |
| May 06, 2021 | Eva C Boratto | EVP & CFO | -4.91K | $80.00 | -$392.40K | SELL | -4.00% | 117.57K | May 04 | View |
| Apr 23, 2021 | Thomas M Moriarty | EVP & GENERAL COUNSEL | -2.42K | $65.59 | -$2.49M | SELL | -5.05% | 45.46K | Apr 21 | View |
| Apr 01, 2021 | James D. Clark | SVP, CONT & CHIEF ACCT OFFICER | 0.00 | $75.15 | -$9.15K | SELL-OPTIONS | 0.00% | 23.89K | Mar 31 | View |
| Mar 30, 2021 | Thomas M Moriarty | EVP & GENERAL COUNSEL | 0.00 | $75.22 | -$117.07K | SELL-OPTIONS | 0.00% | 45.46K | Mar 29 | View |
| Mar 29, 2021 | Jonathan C Roberts | EVP & CHIEF OPERATING OFFICER | 0.00 | $74.39 | -$14.69K | SELL-OPTIONS | 0.00% | 323.65K | Mar 26 | View |
| Mar 29, 2021 | Larry J Merlo | DIRECTOR | 697.00 | $74.51 | -$67.31K | SELL-OPTIONS | 0.06% | 1.21M | Mar 26 | View |
| Mar 23, 2021 | Thomas M Moriarty | EVP & GENERAL COUNSEL | -49.21K | $74.15 | -$3.65M | SELL | -43.59% | 63.68K | Mar 19 | View |
| Mar 17, 2021 | Eva C Boratto | EVP & CFO | 0.00 | $74.49 | -$7.36K | SELL-OPTIONS | 0.00% | 74.76K | Mar 16 | View |
| Feb 17, 2021 | Edward J Ludwig | DIRECTOR | 3.00K | $72.00 | $216.00K | BUY | 13.39% | 25.41K | Feb 17 | View |
| Jan 21, 2021 | Larry J Merlo | PRESIDENT AND CEO | 1.46K | $75.65 | -$62.20K | SELL-OPTIONS | 0.12% | 1.21M | Jan 19 | View |
| Jan 13, 2021 | Lisa Bisaccia | EVP AND CHIEF HR OFFICER | 0.00 | $75.65 | -$68.23K | SELL-OPTIONS | 0.00% | 78.61K | Jan 12 | View |
| Jan 12, 2021 | Alan Lotvin | EVP AND PRESIDENT-CVS CAREMARK | 0.00 | $70.72 | -$221.35K | SELL-OPTIONS | 0.00% | 37.01K | Jan 08 | View |
| Jan 12, 2021 | Troyen Brennan | EVP AND CHIEF MEDICAL OFFICER | -4.35K | $74.65 | -$364.68K | SELL | -3.84% | 108.94K | Jan 08 | View |
| Nov 17, 2020 | Alan Lotvin | — | -7.14K | $70.00 | -$499.66K | SELL | -16.30% | 36.67K | Nov 13 | View |
| Nov 12, 2020 | Joshua M. Flum | — | 0.00 | $52.48 | -$751.96K | OPTION EXERCISE | 0.00% | 36.54K | Nov 10 | View |
| May 28, 2020 | Jonathan E Mayhew | — | -10.56K | $65.00 | -$686.14K | SELL | -67.25% | 5.14K | May 26 | View |
| May 28, 2020 | James D. Clark | — | -270.00 | $65.00 | -$17.55K | SELL | -1.08% | 24.75K | May 26 | View |
| May 13, 2020 | Alan Lotvin | — | 5.00K | $63.13 | $315.68K | PURCHASE | 13.08% | 43.24K | May 11 | View |
| Apr 30, 2020 | James D. Clark | — | -6.23K | $65.00 | -$405.21K | SELL | -19.95% | 25.02K | Apr 28 | View |
| Apr 01, 2020 | James D. Clark | — | 0.00 | $57.27 | -$16.57K | OPTION EXERCISE | 0.00% | 24.49K | Mar 30 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.